The Virta Method
Personalized nutrition tailored to each member's unique metabolism
Company profile
Company profile
Virta Health is a leader in metabolic disease reversal, specializing in type 2 diabetes reversal and sustainable weight loss through a personalized, nutrition-first approach. The company delivers virtual care through an easy-to-use mobile app that connects members with physicians, nurse practitioners, and health coaches who provide high-touch, individualized support. Virta's proprietary methodology, The Virta Method™, focuses on personalized nutrition tailored to each member's unique metabolism, emphasizing whole foods low in sugar and carbohydrates while incorporating healthy fats and proteins. This approach addresses the root cause of metabolic dysfunction rather than simply managing symptoms. The platform includes continuous remote monitoring using connected devices like digital scales and blood glucose meters, along with AI-powered nutrition support called Virta Metabolic Intelligence that helps members understand how food choices affect their body and progress. Virta partners with employers, health plans, and healthcare providers across all 50 states to deliver transformative outcomes. The company's clinical results demonstrate an average weight loss of 31 pounds, 63% medication elimination rate among diabetes patients, and an average A1c reduction of 1.3 points at one year. Virta also offers integrated GLP-1 medication management as part of its comprehensive approach to weight loss and metabolic health. The company is on a mission to solve the nation's diabetes and obesity epidemics by making disease reversal—not just management—the new standard of care.
Company description Virta Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded deployment with recorded integration context.
Company milestones
Published Inaugural Report on Metabolic Disease Reversal; launched Virta Metabolic Intelligence AI-powered nutrition support; expanded GLP-1 medication management program (Virta for Weight Loss+); new USDA Dietary Guidelines co-authored by Virta co-founder reflecting nutrition-first approach
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Personalized nutrition tailored to each member's unique metabolism
Monitor and control blood sugar while providing a path to reversal
Safely deprescribe diabetes medications and return blood sugar to subdiabetic levels
Deliver clinically significant weight loss comparable to existing weight-loss drugs
Nutrition-first care paired with GLP-1 medications and expert management
AI-powered nutrition support showing how food choices affect your body
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Diabetes therapy : research, treatment and education of diabetes and related disorders · Aug 11, 2026
Effectiveness of Telehealth Low-Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real-World, Retrospective, Matched Cohort Study.Diabetes, obesity & metabolism · Jul 16, 2026
Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".Cancer · Jul 1, 2026
Narrative Review: Sugar and Rice and the Diabetes Epidemic in India-A Historical Context.Nutrients · Jun 18, 2026
Broad-Spectrum Effects of Carbohydrate Reduction on Inflammatory and Immune Mediators in Type 2 Diabetes.Endocrine research · May 1, 2026
Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States.Hepatology (Baltimore, Md.) · Mar 17, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
At one year for members with type 2 diabetes
Percent of total diabetes prescriptions eliminated (excluding metformin) at one year
Blood sugar improvement at one year
Medication reduction rate
Cumulative weight loss across member population
Internal survey 12/2023-3/2024
Internal survey 4/2024
Integrated metabolic care for health plan members with diabetes, prediabetes, and obesity
Diabetes reversal and weight loss after Ozempic
Lost 110 pounds, reversed diabetes, eliminated Ozempic and several diabetes medications, walking 8-10 miles daily
Diabetes reversal and medication reduction
A1c reduced from 11% to 6% in 10 weeks, insulin reduced from 110 units to 3 units daily
Diabetes reversal and medication elimination
Got off insulin and saved $500/month
Type 2 diabetes reversal and weight loss
A1c reduced from uncontrolled to 5.5%, lost 65 pounds, cholesterol improved, BMI normalized
Weight loss and medication reduction avoiding bariatric surgery
Lost 65 pounds, reduced medications
Diabetes reversal in high-risk population
Reversed diabetes, lost over 20 pounds, regained energy
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Virta Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.